The cannabis company reported a 32% revenue increase for its popular ancillary brand, Storz & Bickel. Additionally, medical cannabis sales revenue grew 16% in Canada and 12% in international markets.

Net revenue was down 9% quarter-over-quarter, while margins improved across the board.

We’ll discuss all of this, plus find out what contributed to the softness in top-line growth, along with Klein’s main objectives for the company between now and his planned retirement in March 2025.

#canooygrowth #cannabis #cannabisstocks #cannabisindustry #msos #stocks

Want to see more from Canopy Growth?

   • Cannabis industry: Canopy Growth CEO ...     • Canopy Growth CEO Comments on Latest ...  

Want to be updated on Cannabis, Small Cap, AI, and Crypto? Subscribe to our Daily Baked in Newsletter!

https://newsletter.thedalesreport.com...

Find us as well on Facebook, Twitter, Instagram, LinkedIn and on the Web:

Facebook:   / thedalesreport  

Twitter:   / thedalesreport  

Instagram:   / dalesreport  

Apple Podcasts: https://tinyurl.com/TDRTradetoBlackon...

Spotify: https://tinyurl.com/TDRTradeToBlackon...

Website: https://thedalesreport.com/

For copyright matters, please get in touch with us at:

All views on the Trade To Black podcast and the guests on this podcast are purely opinions. You should not treat any opinions expressed by us or our guests as investment advice. The views on this podcast are solely intended to be informational and are not investment advice. Please go to our website for a full list of disclosures and details of any client relationship we have.

https://thedalesreport.com/website-te...